Education
About Us
Working with TipRanks
Follow Us
Bio-Gate AG (DE:BIG1)
XETRA:BIG1
BIG1 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.56 - €1.45
Previous CloseN/A
Volume2.02K
Average Volume (3M)9.13K
Market Cap
€9.34M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.38
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding9,243,691
10 Day Avg. Volume10,909
30 Day Avg. Volume9,126
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BIG1 FAQ
What was Bio-Gate AG’s price range in the past 12 months?
Bio-Gate AG lowest stock price was €0.56 and its highest was €1.45 in the past 12 months.
What is Bio-Gate AG’s market cap?
Bio-Gate AG’s market cap is €9.34M.
When is Bio-Gate AG’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bio-Gate AG’s earnings last quarter?
Currently, no data Available
Is Bio-Gate AG overvalued?
According to Wall Street analysts Bio-Gate AG’s price is currently Overvalued.
Does Bio-Gate AG pay dividends?
Bio-Gate AG does not currently pay dividends.
What is Bio-Gate AG’s EPS estimate?
Bio-Gate AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bio-Gate AG have?
Bio-Gate AG has 9,243,691 shares outstanding.
What happened to Bio-Gate AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bio-Gate AG?
Currently, no hedge funds are holding shares in DE:BIG1
Bio-Gate AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-6.48%
12-Months-Change
Fundamentals
Return on Equity
-69.75%
Trailing 12-Months
Asset Growth
-14.09%
Trailing 12-Months
Company Description
Bio-Gate AG
Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.